Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor

Background. Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets are a major source for circulating microRNAs. Interestingly, the levels of specific microRNAs were reported to correlate with the level of platelet activation. The aim of the present study was to test whether the treatment with the novel antiplatelet agent, ticagrelor, is associated with modulation in the levels of key platelet-derived microRNAs. Methods and Results. Patients were randomly selected from those participating in the SHIFT-OVER study, in which we had previously evaluated the effect of the therapeutic switch from clopidogrel to ticagrelor on platelet aggregation. Circulating levels of selected microRNAs were measured before and after the therapeutic switch from a dual antiplatelet therapy including acetylsalicylic acid (ASA) and clopidogrel to the more potent ticagrelor. Interestingly, the circulating levels of miR-126 (p = 0.030), miR-223 (p = 0.044), and miR-150 (p = 0.048) were significantly reduced, while the levels of miR-96 were increased (p = 0.038). No substantial differences were observed for the remaining microRNAs. Conclusions. Switching from a dual antiplatelet treatment with clopidogrel to ticagrelor is associated with significant modulation in the circulating levels of specific microRNAs. If confirmed in larger, independent cohorts, our results pave the way for the use of circulating microRNAs as biomarkers of platelets activity in response to specific pharmacological treatments.

[1]  C. Indolfi,et al.  MicroRNAs for Restenosis and Thrombosis After Vascular Injury. , 2016, Circulation research.

[2]  P. Provost,et al.  Platelet microparticles reprogram macrophage gene expression and function , 2015, Thrombosis and Haemostasis.

[3]  David D. McManus,et al.  MicroRNAs in platelet function and cardiovascular disease , 2015, Nature Reviews Cardiology.

[4]  Remo Proietti Zaccaria,et al.  Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain , 2015, Science Advances.

[5]  P. Wołkow,et al.  Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report , 2015, Platelets.

[6]  Wen-jie Ji,et al.  The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy , 2015, BioMed research international.

[7]  C. Indolfi,et al.  Circulating microRNAs as Biomarkers in Cardiovascular Diseases. , 2015, Experientia supplementum.

[8]  C. Indolfi,et al.  Administration of a Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch From Ongoing Clopidogrel Treatment to Ticagrelor in Patients With Acute Coronary Syndrome , 2014, Circulation. Cardiovascular interventions.

[9]  A. Curcio,et al.  Emerging role of microRNAs in cardiovascular diseases. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[10]  Hugh S Markus,et al.  Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.

[11]  M. Mayr,et al.  Prospective study on circulating MicroRNAs and risk of myocardial infarction. , 2012, Journal of the American College of Cardiology.

[12]  Mark Ziemann,et al.  Microparticles: major transport vehicles for distinct microRNAs in circulation , 2012, Cardiovascular research.

[13]  S. Fichtlscherer,et al.  Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.

[14]  L. Edelstein,et al.  MicroRNAs in platelet production and activation. , 2010, Blood.

[15]  Zhe Zhang,et al.  MicroRNA expression in maturing murine megakaryocytes. , 2010, Blood.

[16]  Stefanie Dimmeler,et al.  Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.

[17]  Dajiang J. Liu,et al.  VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA , 2010, Journal of thrombosis and haemostasis : JTH.

[18]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[19]  J. Prchal,et al.  Aberrant expression of microRNA in polycythemia vera , 2008, Haematologica.

[20]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.